Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT6021, an ADCC-enhanced Monoclonal Antibody Targeting TIGIT for the Treatment of Solid Tumors

GUANGZHOU, China--(BUSINESS WIRE)--#AUSTRALIA--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1...

news_6

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT6021, an ADCC-enhanced Monoclonal Antibody Targeting TIGIT for the Treatment of Solid Tumors

GUANGZHOU, China--(BUSINESS WIRE)--#AUSTRALIA--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1...

news_6

Hong Kong Wound Dressing Market Analysis and Revenue Forecast Report 2021-2030: Shift in Consumer Preference from Traditional Products to Advanced Therapies – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hong Kong Wound Dressing Market Research Report: By Type, Application, End User, Distribution Channel - Industry Analysis and...

news_6

India Shared Mobility Markets, Competitive Analysis and Growth Forecast Report 2021-2025 – Ongoing Technological Developments & Increasing Investments from Investors – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Shared Mobility Market Research Report: By Service Type, Vehicle Type, Commuting Pattern, End Use, Region - Competitive...

news_6

BeiGene Announces Positive Findings from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy in First-Line Gastric or Gastroesophageal Junction Cancer

In the RATIONALE 305 trial, tislelizumab combined with chemotherapy prolonged overall survival for patients with PD-L1 expression Additional follow-up is...

news_6

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Chegg, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – CHGG

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chegg, Inc....